Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kyle Hadden

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Vitamins and Hormones|February 2, 2016
Hedgehog and Vitamin D Signaling Pathways in Development and DiseaseM Kyle Hadden
Chemmedchem|November 9, 2013
Hedgehog pathway agonism: therapeutic potential and small-molecule developmentM Kyle Hadden
Expert Opinion on Therapeutic Patents|March 17, 2015
Targeting GLI proteins in human cancer by small molecules (WO2014116651 A1): a patent evaluationM Kyle Hadden
European Journal of Medicinal Chemistry|September 15, 2012
Oncoepigenomics: making histone lysine methylation countDaniel Decarlo, M Kyle Hadden
European Journal of Medicinal Chemistry|February 26, 2021
Medulloblastoma drugs in development: Current leads, trials and drawbacksJiachen Wen, M Kyle Hadden
Chemical Biology & Drug Design|September 26, 2012
Identification of small molecule Hes1 modulators as potential anticancer chemotherapeuticsVibhavari Sail, M Kyle Hadden
European Journal of Medicinal Chemistry|November 29, 2021
Affinity-based protein profiling identifies vitamin D3 as a heat shock protein 70 antagonist that regulates hedgehog transduction in murine basal cell carcinomaJiachen Wen, M Kyle Hadden
Chemmedchem|February 7, 2018
Structure-Activity Relationship Studies of Vitamin D3 Analogues Containing an Ether or Thioether Linker as Hedgehog Pathway InhibitorsJiachen Wen, M Kyle Hadden
Bioorganic & Medicinal Chemistry Letters|August 7, 2017
Synthesis and evaluation of vitamin D3 analogues with C-11 modifications as inhibitors of Hedgehog signalingChad A Maschinot, M Kyle Hadden
Anti-Cancer Agents in Medicinal Chemistry|January 1, 2013
Targeting the fibroblast growth factor receptors for the treatment of cancerSteven M Lemieux, M Kyle Hadden
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Vitamins and Hormones|February 2, 2016
Hedgehog and Vitamin D Signaling Pathways in Development and DiseaseM Kyle Hadden
Chemmedchem|November 9, 2013
Hedgehog pathway agonism: therapeutic potential and small-molecule developmentM Kyle Hadden
Expert Opinion on Therapeutic Patents|March 17, 2015
Targeting GLI proteins in human cancer by small molecules (WO2014116651 A1): a patent evaluationM Kyle Hadden
European Journal of Medicinal Chemistry|September 15, 2012
Oncoepigenomics: making histone lysine methylation countDaniel Decarlo, M Kyle Hadden
European Journal of Medicinal Chemistry|February 26, 2021
Medulloblastoma drugs in development: Current leads, trials and drawbacksJiachen Wen, M Kyle Hadden
Chemical Biology & Drug Design|September 26, 2012
Identification of small molecule Hes1 modulators as potential anticancer chemotherapeuticsVibhavari Sail, M Kyle Hadden
European Journal of Medicinal Chemistry|November 29, 2021
Affinity-based protein profiling identifies vitamin D3 as a heat shock protein 70 antagonist that regulates hedgehog transduction in murine basal cell carcinomaJiachen Wen, M Kyle Hadden
Chemmedchem|February 7, 2018
Structure-Activity Relationship Studies of Vitamin D3 Analogues Containing an Ether or Thioether Linker as Hedgehog Pathway InhibitorsJiachen Wen, M Kyle Hadden
Bioorganic & Medicinal Chemistry Letters|August 7, 2017
Synthesis and evaluation of vitamin D3 analogues with C-11 modifications as inhibitors of Hedgehog signalingChad A Maschinot, M Kyle Hadden
Anti-Cancer Agents in Medicinal Chemistry|January 1, 2013
Targeting the fibroblast growth factor receptors for the treatment of cancerSteven M Lemieux, M Kyle Hadden
Pageof 8